Business

Hims & Hers Health, Inc. Reports First Quarter 2025 Financial Results

SAN FRANCISCO, May 05, 2025--Hims & Hers Health, Inc. ("Hims & Hers" or the "Company", NYSE: HIMS), the leading health and wellness platform, today announced financial results for the first quarter ended March 31, 2025, in a shareholder letter that is posted at investors.hims.com.

articleHims & Hers Health, Inc.May 5, 202521/company/hims-hers-health-inc/news/hims-hers-health-inc-reports-200500134
Hims & Hers Health, Inc. Reports First Quarter 2025 Financial Results

About this update from Hims & Hers Health, Inc.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":2562,"height":408,"url":"https://media.zenfs.com/en/business-wire.com/fb60fea391080be3891085e29cf80232"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/lGlxHa4lK.28NOo.fJI6lQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTE1MztjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/fb60fea391080be3891085e29cf80232","width":960,"height":153},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/6IQhhscvpVZ62LqgUR.K9g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0zODI7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/fb60fea391080be3891085e29cf80232","width":1200,"height":191}},"lazy":false},{"type":"text","content":"Revenue of $586.0 million, up 111% year-over-year in Q1 2025","length":60,"tagName":"p","attribs":{}},{"type":"text","content":"Net income of $49.5 million; Adjusted EBITDA of $91.1 million in Q1 2025","length":72,"tagName":"p","attribs":{}},{"type":"text","content":"Subscribers grew to 2.4 million, up 38% year-over-year in Q1 2025","length":65,"tagName":"p","attribs":{}},{"type":"text","content":"Affirms full year 2025 revenue guidance of $2.3 billion to $2.4 billion and raises Adjusted EBITDA guidance to a range of $295 million to $335 million","length":150,"tagName":"p","attribs":{}},{"type":"text","content":"Introduces 2030 targets of at least $6.5 billion in revenue and $1.3 billion in Adjusted EBITDA","length":95,"tagName":"p","attribs":{}},{"type":"text","content":"SAN FRANCISCO, May 05, 2025--(BUSINESS WIRE)--Hims & Hers Health, Inc. ("Hims & Hers" or the "Company", NYSE: HIMS), the leading health and wellness platform, today announced financial results for the first quarter ended March 31, 2025, in a shareholder letter that is posted at investors.hims.com.","length":326,"tagName":"p"},{"type":"text","content":""We’re starting 2025 with incredible momentum. Millions of people are turning to us for access to care that is personal, affordable, and has the potential to drive better outcomes," said Andrew Dudum, co-founder and CEO. "We’re building a platform that puts the individual at the center of every decision and others are taking notice. Over time, we expect wider collaboration across the industry, inclusive of pharmaceutical players, innovative l...

More updates from Hims & Hers Health, Inc.

Free Cash FlowFree Cash Flow